News: Legal and Regulatory
Latest in Legal and Regulatory
OSI Pharmaceuticals has announced that its board of directors has unanimously rejected an unsolicited $3.5bn conditional tender offer from Astellas US Holding, a subsidiary of Japans Astellas Pharma.
16 March 2010
Ranbaxy and Takeda Settle Diabetes Drug Dispute
15 March 2010
15 March 2010
Daiichi Sankyo Sees Ranbaxy Freedom as Key to Growth
12 March 2010
12 March 2010
Dainippon Schizophrenia Drug Set for Review in US
11 March 2010
11 March 2010
FDA Approves Botox as Post-Stroke Joint Treatment
10 March 2010
10 March 2010
CombinatoRx's Chronic Painkiller Gets FDA Approval
08 March 2010
08 March 2010
US Court Upholds Shire's ADHD Drug Exclusivity
05 March 2010
05 March 2010
FDA and EPA Simplify Orphan Drug Development Process
05 March 2010
05 March 2010
FDA Approves Novo Nordisk's Growth Hormone Treatment
04 March 2010
04 March 2010
